We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
At Home (HOME) Q2 Earnings Beat Estimates, Inventory Low
Read MoreHide Full Article
At Home Group Inc. fell more than 14% in the after-hours trading session despite impressive results for second-quarter fiscal 2021. The top and bottom lines topped the Zacks Consensus Estimate and grew significantly from the year-ago period.
Investors’ sentiments might have been hurt by moderating business prospects for the remainder of fiscal 2021 due to meaningful increase in the seasonal mix and inventory constraints. Also, the ongoing competitor liquidations, and uncertainty related to the COVID-19 pandemic and elections may weigh on its future results. At Home projects seasonal inventory to decline 20% and 10% in the fiscal third and fourth quarters, respectively.
Inside the Headlines
The company reported adjusted earnings per share of $1.41, which topped the consensus estimate of $1.33 by 6% and increased a notable 683% from 18 cents reported a year ago.
At Home Group Inc. Price, Consensus and EPS Surprise
Net sales of $515.2 million also beat the consensus mark of $515 million by 0.5% and grew 50.5% from $342.3 million generated last year. The upside was driven by a 42.3% improvement in comparable store sales or comps and 7.4% net increase in stores. Strong demand and persistent rollout of its omni-channel initiatives helped it achieve improved comps.
Operating Highlights
Gross margin of 38.1% expanded 880 basis points (bps) from the year-ago figure of 29.3% backed by lower occupancy costs, depreciation expense and distribution center costs. Adjusted selling, general and administrative expenses — as a percentage of net sales — improved 900 bps year over year to 13%.
Consequently, adjusted operating margin increased a significant 1,780 bps to 24.6% from the prior-year level owing to the above-mentioned tailwinds. Adjusted EBITDA was $159.7 million compared with $47.1 million a year ago, reflecting growth of 239.1%.
At fiscal second quarter-end, the company had 219 stores in 40 states. Out of these, 15 net new stores were opened in the last year.
Financials
As of Jul 25, 2020, At Home reported cash and cash equivalents of $32.4 million compared with $12.1 million at fiscal 2020-end and $13.1 million at the end of fiscal second-quarter 2020. Inventories were down 30% at the end of the reported quarter, primarily due to strong demand for its products post the easing of coronavirus-led restrictions.
Long-term debt came in at $359.5 million at fiscal second quarter-end compared with $334.3 million at fiscal 2020-end.
Net cash provided by operating activities was $234.5 million in the first six months of fiscal 2021 compared with $11.4 million in the corresponding period of fiscal 2020. As of Jul 25, 2020, it had total liquidity of $305.8 million.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
At Home (HOME) Q2 Earnings Beat Estimates, Inventory Low
At Home Group Inc. fell more than 14% in the after-hours trading session despite impressive results for second-quarter fiscal 2021. The top and bottom lines topped the Zacks Consensus Estimate and grew significantly from the year-ago period.
Investors’ sentiments might have been hurt by moderating business prospects for the remainder of fiscal 2021 due to meaningful increase in the seasonal mix and inventory constraints. Also, the ongoing competitor liquidations, and uncertainty related to the COVID-19 pandemic and elections may weigh on its future results. At Home projects seasonal inventory to decline 20% and 10% in the fiscal third and fourth quarters, respectively.
Inside the Headlines
The company reported adjusted earnings per share of $1.41, which topped the consensus estimate of $1.33 by 6% and increased a notable 683% from 18 cents reported a year ago.
At Home Group Inc. Price, Consensus and EPS Surprise
At Home Group Inc. price-consensus-eps-surprise-chart | At Home Group Inc. Quote
Net sales of $515.2 million also beat the consensus mark of $515 million by 0.5% and grew 50.5% from $342.3 million generated last year. The upside was driven by a 42.3% improvement in comparable store sales or comps and 7.4% net increase in stores. Strong demand and persistent rollout of its omni-channel initiatives helped it achieve improved comps.
Operating Highlights
Gross margin of 38.1% expanded 880 basis points (bps) from the year-ago figure of 29.3% backed by lower occupancy costs, depreciation expense and distribution center costs. Adjusted selling, general and administrative expenses — as a percentage of net sales — improved 900 bps year over year to 13%.
Consequently, adjusted operating margin increased a significant 1,780 bps to 24.6% from the prior-year level owing to the above-mentioned tailwinds. Adjusted EBITDA was $159.7 million compared with $47.1 million a year ago, reflecting growth of 239.1%.
At fiscal second quarter-end, the company had 219 stores in 40 states. Out of these, 15 net new stores were opened in the last year.
Financials
As of Jul 25, 2020, At Home reported cash and cash equivalents of $32.4 million compared with $12.1 million at fiscal 2020-end and $13.1 million at the end of fiscal second-quarter 2020. Inventories were down 30% at the end of the reported quarter, primarily due to strong demand for its products post the easing of coronavirus-led restrictions.
Long-term debt came in at $359.5 million at fiscal second quarter-end compared with $334.3 million at fiscal 2020-end.
Net cash provided by operating activities was $234.5 million in the first six months of fiscal 2021 compared with $11.4 million in the corresponding period of fiscal 2020. As of Jul 25, 2020, it had total liquidity of $305.8 million.
Zacks Rank
At Home — which shares space with RH (RH - Free Report) , Tempur Sealy International, Inc. (TPX - Free Report) and The Lovesac Company (LOVE - Free Report) in the Zacks Retail - Home Furnishings industry — currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>